The ambiguous role of mannose-binding lectin (MBL) in human immunity

Mannose-binding lectin (MBL) and lectin complement pathway have become targets of increasing clinical interest. Many aspects of MBL have been recently explored, including the structural properties that allow it to distinguish self from non-self/altered-self structures. Experimental evidences have de...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kalia Namarta, Singh Jatinder, Kaur Manpreet
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
R
Acceso en línea:https://doaj.org/article/751cbc5a79354ae39f1271575d56a4a3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:751cbc5a79354ae39f1271575d56a4a3
record_format dspace
spelling oai:doaj.org-article:751cbc5a79354ae39f1271575d56a4a32021-12-05T14:10:54ZThe ambiguous role of mannose-binding lectin (MBL) in human immunity2391-546310.1515/med-2021-0239https://doaj.org/article/751cbc5a79354ae39f1271575d56a4a32021-02-01T00:00:00Zhttps://doi.org/10.1515/med-2021-0239https://doaj.org/toc/2391-5463Mannose-binding lectin (MBL) and lectin complement pathway have become targets of increasing clinical interest. Many aspects of MBL have been recently explored, including the structural properties that allow it to distinguish self from non-self/altered-self structures. Experimental evidences have declared the additional 5′- and 3′-variants that in amalgamation with well-known secretor polymorphisms change MBL function and concentration. Moreover, the current review highlights the differential behavior of MBL on exposure with extra/intracellular pathogens and in autoimmune diseases, stressing the fact that “high MBL levels can increase diseases susceptibility,” a paradox that needs justification. Attributable to these discrepancies, no absolute level of MBL deficiency could be defined so far and thus must be interpreted for specific diseases through case–control population-specific designs. Overall, it is evident that further research is needed about MBL and the lectin pathway of complement. Particularly, the transformative role of MBL over evolution is of interest and its role with regard to pathogenesis of different diseases and potential therapeutic targets within the respective pathways should be further explored. Apart from this, it is necessary to adopt an extensive locus-wide methodology to apprehend the clinical significance of MBL2 polymorphisms in a variety of infectious diseases by the future studies.Kalia NamartaSingh JatinderKaur ManpreetDe Gruyterarticleinfectious diseasesautoimmune diseasessingle nucleotide polymorphismsfunctional snps5′ near gene3′utrvariantsphagocytosis and mbl patentsMedicineRENOpen Medicine, Vol 16, Iss 1, Pp 299-310 (2021)
institution DOAJ
collection DOAJ
language EN
topic infectious diseases
autoimmune diseases
single nucleotide polymorphisms
functional snps
5′ near gene
3′utr
variants
phagocytosis and mbl patents
Medicine
R
spellingShingle infectious diseases
autoimmune diseases
single nucleotide polymorphisms
functional snps
5′ near gene
3′utr
variants
phagocytosis and mbl patents
Medicine
R
Kalia Namarta
Singh Jatinder
Kaur Manpreet
The ambiguous role of mannose-binding lectin (MBL) in human immunity
description Mannose-binding lectin (MBL) and lectin complement pathway have become targets of increasing clinical interest. Many aspects of MBL have been recently explored, including the structural properties that allow it to distinguish self from non-self/altered-self structures. Experimental evidences have declared the additional 5′- and 3′-variants that in amalgamation with well-known secretor polymorphisms change MBL function and concentration. Moreover, the current review highlights the differential behavior of MBL on exposure with extra/intracellular pathogens and in autoimmune diseases, stressing the fact that “high MBL levels can increase diseases susceptibility,” a paradox that needs justification. Attributable to these discrepancies, no absolute level of MBL deficiency could be defined so far and thus must be interpreted for specific diseases through case–control population-specific designs. Overall, it is evident that further research is needed about MBL and the lectin pathway of complement. Particularly, the transformative role of MBL over evolution is of interest and its role with regard to pathogenesis of different diseases and potential therapeutic targets within the respective pathways should be further explored. Apart from this, it is necessary to adopt an extensive locus-wide methodology to apprehend the clinical significance of MBL2 polymorphisms in a variety of infectious diseases by the future studies.
format article
author Kalia Namarta
Singh Jatinder
Kaur Manpreet
author_facet Kalia Namarta
Singh Jatinder
Kaur Manpreet
author_sort Kalia Namarta
title The ambiguous role of mannose-binding lectin (MBL) in human immunity
title_short The ambiguous role of mannose-binding lectin (MBL) in human immunity
title_full The ambiguous role of mannose-binding lectin (MBL) in human immunity
title_fullStr The ambiguous role of mannose-binding lectin (MBL) in human immunity
title_full_unstemmed The ambiguous role of mannose-binding lectin (MBL) in human immunity
title_sort ambiguous role of mannose-binding lectin (mbl) in human immunity
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/751cbc5a79354ae39f1271575d56a4a3
work_keys_str_mv AT kalianamarta theambiguousroleofmannosebindinglectinmblinhumanimmunity
AT singhjatinder theambiguousroleofmannosebindinglectinmblinhumanimmunity
AT kaurmanpreet theambiguousroleofmannosebindinglectinmblinhumanimmunity
AT kalianamarta ambiguousroleofmannosebindinglectinmblinhumanimmunity
AT singhjatinder ambiguousroleofmannosebindinglectinmblinhumanimmunity
AT kaurmanpreet ambiguousroleofmannosebindinglectinmblinhumanimmunity
_version_ 1718371611819638784